Olberon’s Novel Products Attracting Interest Around the World

Nottingham medical device company, Olberon Ltd, are experiencing significant interest for its existing and pipeline products despite the COVID 19 pandemic. The company, founded by Dr Arash Bakhtyari, a Nottingham Radiologist, develop and commercialise innovative medical device concepts that originate from direct experience of patient care. Dr Bakhtyari explained “This...

The UK life sciences market after December 2020 – medical devices

UK Government has issued a series of new Brexit guidance documents for the life sciences sector. With the transition period coming to an end on 31 December 2020, the Medicines and Healthcare products Regulatory Agency (MHRA) will take on its role as the UK’s standalone medicines and medical devices regulator in under...

Deloitte to launch health tech innovation hub

Deloitte is launching a Health Tech Catalyst in Birmingham that will be a collaborative platform for those responsible for developing, or investing in digital solutions for frontline care. Its aim is to accelerate health tech innovation in the Midlands and beyond, which could ultimately improve people’s health and wellbeing. The decision to...

Spirit Digital enables re-introduction of Cardiopulmonary Rehabilitation services through its remote monitoring platform, CliniTouch Vie

Spirit Digital today announces that CCGs across the UK whose Cardiopulmonary Rehabilitation services were suspended during COVID-19 will be able to restart these services supported by its digital, remote monitoring platform, CliniTouch Vie. As the government aims to substantially increase referral rates, CliniTouch Vie will enable clinical teams to remotely...

Accelerator programme for digital health innovators open for applications

The East Midlands Academic Health Science Network's East Midlands Digital Health Accelerator is designed to help companies further the spread of their digital health technologies and innovations within the NHS, with a tailored package of expert support available to successful applicants. Support is tailored to the need of the business...

Anthony Nolan Cell & Gene Therapy Services and the Medical Technology Innovation Facility (MTIF) enter into a Memorandum of Understanding

Agreement will accelerate the development of innovative cell therapies to improve the lives of patients. Blood cancer charity Anthony Nolan’s Cell & Gene Therapy Services and the Medical Technology Innovation Facility (MTIF) have entered into a Memorandum of Understanding (MoU) to accelerate the development of innovative cell therapies to improve the lives of patients. Together, they provide a centralised hub of...

Medilink Patron, Datalink Electronics, joins forces as a partner in a £1.7M grant funded project with MicroBioSensor and Smallfry

The project will be focused on the development of an electronic test system that can rapidly detect peritonitis in vulnerable patients with kidney or liver failure and identify the effective antibiotic for its treatment. Patients with advanced kidney disease, who are reliant on peritoneal dialysis (PD), as well as advanced...